Correction to: Bioelectron Med (2020) 6:4
https://doi.org/10.1186/s42234-020-0040-0
The original version of this article (Habelt et al. 2020), published on 17 February 2020, contained incorrect sentence. In this Correction the affected part of the article is shown.
1. Incorrect sentence;
"(...) Lapenta et al. (2014) observed a decreased N2 and enhanced P3 amplitude for visual NoGo stimuli after a single bilateral tDCS session in obese patients."
2. Correct sentence;
"(...) Lapenta et al. (2014) observed a decreased N2 and enhanced P3 amplitude for visual NoGo stimuli after a single bilateral tDCS session in normal weight subjects."
Reference
Habelt B, et al. Biomarkers and neuromodulation techniques in substance use disorders. Bioelectron Med. 2020;6:4. https://doi.org/10.1186/s42234-020-0040-0.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Habelt, B., Arvaneh, M., Bernhardt, N. et al. Correction to: Biomarkers and neuromodulation techniques in substance use disorders. Bioelectron Med 6, 6 (2020). https://doi.org/10.1186/s42234-020-00043-7
Published:
DOI: https://doi.org/10.1186/s42234-020-00043-7